- Home
- VRDN vs DSGR Comparison
VRDN vs DSGR Comparison
Compare VRDN & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- DSGR
- Stock Information
- Founded
- VRDN 2006
- DSGR 1952
- Country
- VRDN United States
- DSGR United States
- Employees
- VRDN N/A
- DSGR N/A
- Industry
- VRDN Medical Specialities
- DSGR Industrial Machinery/Components
- Sector
- VRDN Health Care
- DSGR Industrials
- Exchange
- VRDN Nasdaq
- DSGR Nasdaq
- Market Cap
- VRDN 1.3B
- DSGR 1.3B
- IPO Year
- VRDN N/A
- DSGR N/A
- Fundamental
- Price
- VRDN $15.67
- DSGR $29.11
- Analyst Decision
- VRDN Strong Buy
- DSGR Buy
- Analyst Count
- VRDN 11
- DSGR 2
- Target Price
- VRDN $38.50
- DSGR $40.50
- AVG Volume (30 Days)
- VRDN 728.3K
- DSGR 52.8K
- Earning Date
- VRDN 08-07-2025
- DSGR 07-31-2025
- Dividend Yield
- VRDN N/A
- DSGR N/A
- EPS Growth
- VRDN N/A
- DSGR N/A
- EPS
- VRDN N/A
- DSGR 0.02
- Revenue
- VRDN $302,000.00
- DSGR $1,866,047,000.00
- Revenue This Year
- VRDN N/A
- DSGR $10.80
- Revenue Next Year
- VRDN $17,102.33
- DSGR $4.10
- P/E Ratio
- VRDN N/A
- DSGR $1,166.60
- Revenue Growth
- VRDN 4.86
- DSGR 13.91
- 52 Week Low
- VRDN $9.90
- DSGR $21.87
- 52 Week High
- VRDN $27.20
- DSGR $41.47
- Technical
- Relative Strength Index (RSI)
- VRDN 61.91
- DSGR 64.11
- Support Level
- VRDN $13.84
- DSGR $27.22
- Resistance Level
- VRDN $14.85
- DSGR $28.07
- Average True Range (ATR)
- VRDN 0.82
- DSGR 0.77
- MACD
- VRDN -0.03
- DSGR 0.17
- Stochastic Oscillator
- VRDN 82.81
- DSGR 89.07
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.